COVID-19 vaccine effectiveness against symptomatic infection and hospitalisation in Belgium, July 2021 to May 2022

BACKGROUND: The Belgian COVID-19 vaccination campaign aimed to reduce disease spread and severity. AIM: We estimated SARS-CoV-2 variant-specific vaccine effectiveness against symptomatic infection (VEi) and hospitalisation (VEh), given time since vaccination and prior infection. METHODS: Nationwide...

Descripción completa

Detalles Bibliográficos
Autores principales: Braeye, Toon, van Loenhout, Joris A F, Brondeel, Ruben, Stouten, Veerle, Hubin, Pierre, Billuart, Matthieu, Chung, Pui Yan Jenny, Vandromme, Mathil, Wyndham-Thomas, Chloé, Blot, Koen, Catteau, Lucy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Centre for Disease Prevention and Control (ECDC) 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10311948/
https://www.ncbi.nlm.nih.gov/pubmed/37382885
http://dx.doi.org/10.2807/1560-7917.ES.2023.28.26.2200768

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10311948/
https://www.ncbi.nlm.nih.gov/pubmed/37382885
http://dx.doi.org/10.2807/1560-7917.ES.2023.28.26.2200768

Ejemplares similares